These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
701 related items for PubMed ID: 9519950
1. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Halsey NA, Coberly JS, Desormeaux J, Losikoff P, Atkinson J, Moulton LH, Contave M, Johnson M, Davis H, Geiter L, Johnson E, Huebner R, Boulos R, Chaisson RE. Lancet; 1998 Mar 14; 351(9105):786-92. PubMed ID: 9519950 [Abstract] [Full Text] [Related]
2. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. Mwinga A, Hosp M, Godfrey-Faussett P, Quigley M, Mwaba P, Mugala BN, Nyirenda O, Luo N, Pobee J, Elliott AM, McAdam KP, Porter JD. AIDS; 1998 Dec 24; 12(18):2447-57. PubMed ID: 9875583 [Abstract] [Full Text] [Related]
4. Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. Johnson JL, Okwera A, Hom DL, Mayanja H, Mutuluuza Kityo C, Nsubuga P, Nakibali JG, Loughlin AM, Yun H, Mugyenyi PN, Vernon A, Mugerwa RD, Ellner JJ, Whalen CC, Uganda-Case Western Reserve University Research Collaboration. AIDS; 2001 Nov 09; 15(16):2137-47. PubMed ID: 11684933 [Abstract] [Full Text] [Related]
7. Isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Colebunders R, Florence E. Lancet; 1998 Jun 13; 351(9118):1813. PubMed ID: 9635977 [No Abstract] [Full Text] [Related]
8. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Vernon A, Burman W, Benator D, Khan A, Bozeman L. Lancet; 1999 May 29; 353(9167):1843-7. PubMed ID: 10359410 [Abstract] [Full Text] [Related]